Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00013286 · ClinicalTrials.gov registry record
A Prospective Study of Endothelial Dysfunction and Diabetic Foot Ulcer Risk
A clinical trial of Diabetic Foot Ulcers, sponsored by US Department of Veterans Affairs.
- Completed
- Registry status
- 750
- Enrollment target
- 1
- Study location
NCT00013286 is a study of Diabetic Foot Ulcers that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 750 participants, above the 172-participant average among 12 other Diabetic Foot Ulcers trials with a reported enrollment target (336% higher). The trial reports 1 study location across 1 state.
The verdict
NCT00013286, a study of Diabetic Foot Ulcers, has completed, sponsored by US Department of Veterans Affairs.
- COMPLETED
- Registry status
- 750 participants
- Enrollment target
- 1
- Study location
Study Summary
This project will identify risk factors for diabetic foot ulcer by studying the relationship between endothelial dysfunction and foot ulcer risk. A fundamental defect in type 1 and 2 diabetic subjects is impaired vasodilatory reserve which is reflected in the dysfunction of endothelium-dependent vasodilation. Findings thus far point to an important role of the microvasculature in the development of diabetic foot ulcer and amputation. In this study a a well-characterized cohort of 750 diabetic veterans without foot ulcer will be followed over 3-years.
Conditions Studied
Interventions
- DEVICE Prevention Diabetic Foot Ulcer
Study Locations (1)
Washington
- VAMC, Seattle, WA - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 750 participants |
| Start Date | 1999-10 |
| Est. Completion | 2002-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00013286
The ClinicalTrials.gov registry entry for NCT00013286 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 750 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 172-participant average among 12 other Diabetic Foot Ulcers trials with a reported enrollment target (336% higher). The listed sponsor is US Department of Veterans Affairs, which has 632 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Diabetic Foot Ulcers appearing as the primary indexed condition, and to 1 intervention - of which Prevention Diabetic Foot Ulcer is the first listed.
NCT00013286 reports 1 study location spanning 1 distinct geographic area - top geographies include Washington.
Frequently Asked Questions
What is clinical trial NCT00013286 about?
NCT00013286 is a clinical study titled "A Prospective Study of Endothelial Dysfunction and Diabetic Foot Ulcer Risk". This project will identify risk factors for diabetic foot ulcer by studying the relationship between endothelial dysfunction and foot ulcer risk. A fundamental defect in type 1 and 2 diabetic subjects is impaired vasodilatory reserve which is reflected in the dysfunction of endothelium-dependent vas...
What is the current status of trial NCT00013286?
This trial is currently completed. The enrollment target is 750 participants. The study started on 1999-10. Estimated completion is 2002-09.
What conditions does trial NCT00013286 study?
This clinical trial studies the following conditions: Diabetic Foot Ulcers.
What interventions are being tested in trial NCT00013286?
The interventions under investigation include: Prevention Diabetic Foot Ulcer (DEVICE).
Who is sponsoring clinical trial NCT00013286?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00013286 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetic Foot Ulcers
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Phase II Study to Evaluate Efficacy and Safety of AMP Peptide PL-5 in Mild Infections of Diabetic Foot Ulcers
ACTIVE NOT RECRUITING · Phase 2
-
Wound Healing Endpoint and Recurrence
ACTIVE NOT RECRUITING · Phase 1
-
Clinical Trials of Footwear in Patients With Diabetes-Study Arm 2,3
COMPLETED · Phase 2
-
Safety Study to Examine the Systemic Exposure of Granexin® Gel After Topical Application to Diabetic Foot Ulcers
COMPLETED · Phase 1
-
MSI-78 Topical Cream vs. Oral Ofloxacin in the Treatment of Infected Diabetic Ulcers
COMPLETED · Phase 3
-
Hyperspectral Imaging to Assess and Predict Diabetic Foot Ulcers
COMPLETED
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.